Tanzania has an estimated 2.9 million adults with diabetes, 35% of whom are undiagnosed, and over 22,000 people living with type 1 diabetes. While the 2023 Universal Health Insurance law aims to improve access to care, only 15% of people are insured. Over 700 clinics provide diabetes care and offer ...free insulin to children and young adults. However, challenges remain regarding insulin availability, diagnostics, patient education and the healthcare workforce. Community engagement, training and policy advocacy are essential for improving diabetes management and achieving universal health coverage.
more
This brochure provides comprehensive information on type 2 diabetes, including its causes, symptoms, risk factors, how to prevent it, and how to manage it. It emphasises the importance of a healthy diet, regular exercise, and taking medication as prescribed to control blood sugar levels. It provides... practical advice on diet and lifestyle changes, as well as foot care, and highlights the importance of regular check-ups and blood glucose monitoring. The guide also warns of potential complications such as low and high blood sugar levels and long-term organ damage, emphasising the importance of early detection and consistent care. It encourages education and community support, such as joining the Zimbabwe Diabetes Association, to help individuals with diabetes live healthy lives.
Accessed on 17/07/2025.
more
Tanzania Journal of Health Research Doi: http://dx.doi.org/10.4314/thrb.v19i4.8 Volume 19, Number 4, October 2017;
Diabetes mellitus (DM) is an increasingly prevalent metabolic disorder and poses a growing public health concern in Tanzania, particularly in rapidly urbanizing areas like Morogoro. T...his cross-sectional study investigated the prevalence of diabetes and its associated risk factors among 129 outpatients at Morogoro Regional Referral Hospital.
more
In 2012, 25.7% of adults in Tanzania aged 25–64 had hypertension, affecting approximately 4 million people. However, most remain unaware of their condition or are not receiving treatment, with only 0.1 million achieving blood pressure control.
Tanzania WASH sector stakeholders collaborated between March and May 2022 to develop this Country WASH M&E Roadmap. The initial vision, outcomes and activities outlined in the Roadmap were established during a workshop, held on 2–3 March 2022, and further refined during a second workshop, held on ...28 April 2022.
more
This case study uses the Astana Primary Health Care (PHC) framework to explore the impact of the 2020–21 pandemic on primary health care in Kenya. While the pandemic exposed systemic challenges, such as limited testing capacity, an inadequate supply of PPE, and weak social protection, Kenya's heal...th system also demonstrated notable adaptability. The response was largely hospital-centred, with PHC playing a secondary role. Nevertheless, innovations emerged on both the provider and consumer sides to maintain service delivery and access. The study emphasises the importance of building on these experiences to enhance emergency preparedness and develop a more robust and integrated health system.
more
The Ministry of Health recognizes that access to safe water, sanitation and hygiene (WASH) in health facilities is critical in the reduction of diseases, improved occupational health, more efficient health care services, improved staff morale and performance. The micro planning data generated will g...uide line ministries, local government authorities and development partners to position WASH in the health care facilities agenda within the Water and Health sectors. Additionally, it will support the development of a roadmap for achieving WASH-related sustainable development goals for health institutions.
more
The Sustainable Development Goals (SDG) 3 and SDG 6 reinforce the need to ensure adequate WASH services, which will result in a reduction in maternal mortality, ending preventable newborn deaths, and providing quality universal health coverage. The rationale of the WASH guidelines is to document pro...cedures and provide a framework for strategic planning, implementation of functional and effective WASH services in healthcare facilities in Uganda. These guidelines offer a basis for creating the minimum conditions required for providing healthcare services in a healthy environment for healthcare workers, patients and visitors to the healthcare premises. They also serve as a tool for monitoring the performance of WASH in health care facilities.
more
Heliyon 2023 Oct 20;9(11):e21286. doi: 10.1016/heliyon.2023.e21286. This study conducted a systematic review of observational, community-based studies from 2013 to 2022, aiming to estimate the prevalence of prediabetes and its associated risk factors within the adult East African population. Twenty...-one studies were analysed, revealing an overall prediabetes prevalence of 12.58%.
more
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
In 2015, 23.7% of Kenyan adults aged 18–69 — around 5.7 million people — had hypertension. However, only 0.2 million of these individuals had their condition under control. Awareness and treatment rates remain low.
On 31 May 2022, the Konrad-Adenauer-Stiftung (KAS) Namibia – Angola Office handed over equipment to the Namibian Federation of the Visually Impaired (NFVI), at their head office in Windhoek. The main objective of this handover is to support the federation with equipment including a Perkins Braille...r Classic Manual and a Tactile Heat Swell Form Machine, to aid the braille/transferal of text to braille. Additionally, to enable the federation to capacitate their members with the necessary resources, to bring crucial information closer to persons with visual impairments (inclusion) and promote practical application of the Namibian Constitution, with special reference to Chapter 3.
more
The Ministry of Health and Social Services (MOHSS) undertook a situation analysis in respect of human resources for health in order to improve health and social services outcomes following varios sector targeted interventions. The situation analysis report covers the period up to December 2018 and r...esults from this situation analysis were presented at various forums for broader discussion and input.
more
Front. Cell. Infect. Microbiol., 12 April 2021 Sec. Parasite and Host
Volume 11 - 2021 | https://doi.org/10.3389/fcimb.2021.656938
Over the past several decades, malaria/HIV-1 co-infection has become a significant global public health problem in co-endemic areas of the world.
Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette
approche a été combinée avec des... activités de lutte antivectorielle. L’objet de ces lignes directrices est donc de la plus haute importance pour la poursuite des progrès en vue de l’élimination de la THA.
more
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...s of the clinical trials of fexinidazole. The screening of the Drugs for Neglected Diseases initiative (DNDi) HAT-library by the Swiss TPH had singled out fexinidazole, originally developed by Hoechst (now Sanofi), as the most promising of a series of over 800 nitroimidazoles and related molecules. In cell culture, fexinidazole has an IC50 of around 1 µM against Trypanosoma brucei and is more than 100-fold less toxic to mammalian cells. In the mouse model, fexinidazole cures both the first, haemolymphatic, and the second, meningoencephalitic stage of the infection, the latter at 100 mg/kg twice daily for 5 days. In patients, the clinical trials managed by DNDi and supported by Swiss TPH mainly conducted in the Democratic Republic of the Congo demonstrated that oral fexinidazole is safe and effective for use against first- and early second-stage sleeping sickness. Based on the positive opinion issued by the European Medicines Agency in 2018, the WHO has released new interim guidelines for the treatment of HAT including fexinidazole as the new therapy for first-stage and non-severe second-stage sleeping sickness caused by Trypanosoma brucei gambiense (gHAT). This greatly facilitates the diagnosis and treatment algorithm for gHAT, increasing the attainable coverage and paving the way towards the envisaged goal of zero transmission by 2030.
more
Research globally has shown that metered dose inhaler (MDI) technique is poor, with patient education and regular demonstration critical in maintaining correct use of inhalers. Patient information containing pictorial aids improves understanding of medicine usage; however, manufacturer leaflets illu...strating MDI use may not be easily understood by low-literacy asthma patients.
more
L’Atelier de mise en œuvre de partenariat constitue une étape importante pour les Partenariats africains pour la sécurité des patients. Les équipes de chaque hôpital africain, suisse et anglais participant au programme ont assisté à l’atelier
dans le but de travailler ensemble dans leur...s partenariats afin de créer des projets de programme destinés à une mise en œuvre sur les deux prochaines années. Le personnel interne clé de l’OMS et les partenaires de la NPSA
(Agence nationale pour la sécurité des patients – Londres, Angleterre) et de THET (Groupe d’experts en éducation et santé tropicale) étaient également présents.
more